Publication:
Treatment costs of pneumonia, meningitis, sepsis, and other diseases among hospitalized children in Viet Nam

dc.contributor.authorDang Duc Anhen_US
dc.contributor.authorArthorn Riewpaiboonen_US
dc.contributor.authorLe Huu Thoen_US
dc.contributor.authorSoon Ae Kimen_US
dc.contributor.authorBatmunkh Nyambaten_US
dc.contributor.authorPaul Kilgoreen_US
dc.contributor.otherNational Institute of Hygiene and Epidemiology Hanoien_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherKhanh Hoa Health Serviceen_US
dc.contributor.otherInternational Vaccine Institute, Seoulen_US
dc.date.accessioned2018-09-24T08:40:19Z
dc.date.available2018-09-24T08:40:19Z
dc.date.issued2010-01-01en_US
dc.description.abstractThe aim of this study was to estimate the costs of treatment of children who present with the signs and symptoms of invasive bacterial diseases in Khanh Hoa province, Viet Nam. The study was an incidencebased cost-of-illness analysis from the health system perspective. The hospital costs included labour, materials and capital costs, both direct and indirect. Costs were determined for 980 children, with an average age of 12.67 months (standard deviation±11.38), who were enrolled in a prospective surveillance at the Khanh Hoa General Hospital during 2005-2006. Of them, 57% were male. By disease-category, 80% were suspected of having pneumonia, 8% meningitis, 3% very severe disease consistent with pneumococcal sepsis, and 9% other diseases. Treatment costs for suspected pneumonia, meningitis, very severe disease, and other diseases were US$ 31, US$ 57, US$ 73, and US$ 24 respectively. Costs ranged from US$ 24 to US$ 164 across different case-categories. Both type of disease and age of patient had statistically significant effects on treatment costs. The results showed that treatment costs for bacterial diseases in children were considerable and might differ by as much as seven times among invasive pneumococcal diseases. Changes in costs were sensitive to both age of patient and case-category. These cost-of-illness data will be an important component in the overall evidence base to guide the development of vaccine policy in Viet Nam. © International Centre for Diarrhoeal Disease Research, Bangladesh.en_US
dc.identifier.citationJournal of Health, Population and Nutrition. Vol.28, No.5 (2010), 436-442en_US
dc.identifier.doi10.3329/jhpn.v28i5.6151en_US
dc.identifier.issn16060997en_US
dc.identifier.other2-s2.0-78349245144en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/28556
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=78349245144&origin=inwarden_US
dc.subjectAgricultural and Biological Sciencesen_US
dc.subjectEnvironmental Scienceen_US
dc.subjectMedicineen_US
dc.titleTreatment costs of pneumonia, meningitis, sepsis, and other diseases among hospitalized children in Viet Namen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=78349245144&origin=inwarden_US

Files

Collections